SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-13-000439
Filing Date
2013-09-16
Accepted
2013-09-16 17:48:59
Documents
2
Period of Report
2013-09-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6650
2 attach_2.htm EX-24 1021
  Complete submission text file 0001012975-13-000439.txt   9012
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Issuer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE - SUITE 3502 NEW YORK NY 10036
Business Address
Ratcliffe Liam (Reporting) CIK: 0001547100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16633 | Film No.: 131099656